Technical University of Munich: Milestone Towards Personalized Prevention of Type 1 Diabetes
November 12, 2025
November 12, 2025
MUNICH, Germany, Nov. 12 (TNSjou) -- The Technical University of Munich issued the following news:
* * *
POInT trial investigates preventive oral insulin treatment for at-risk children
New milestone towards personalized prevention of type 1 diabetes
The Primary Oral Insulin Trial (POInT) investigates whether type 1 diabetes in at-risk children can be prevented through oral insulin treatment. First results mark an important step towards the prev . . .
* * *
POInT trial investigates preventive oral insulin treatment for at-risk children
New milestone towards personalized prevention of type 1 diabetes
The Primary Oral Insulin Trial (POInT) investigates whether type 1 diabetes in at-risk children can be prevented through oral insulin treatment. First results mark an important step towards the prev . . .